HR+/HER2- Breast Cancer

Sydney, Australia, September 1, 2026 Kazia Therapeutics has announced plans to expand its ongoing paxalisib clinical trial into hormone...

SHANGHAI, China, August 12, 2026 Laekna announced that China’s National Medical Products Administration (NMPA) has accepted the New Drug...